相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The 2019 WHO classification of tumours of the digestive system
Iris D. Nagtegaal et al.
HISTOPATHOLOGY (2020)
Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?
Elettra Merola et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
New and emerging systemic therapy options for well-differentiated gastroenteropancreatic neuroendocrine tumors
Steven D. Scoville et al.
EXPERT OPINION ON PHARMACOTHERAPY (2020)
Risk Prediction for Acute Kidney Injury - Super Important, Now suPAR Easy?
Frank Tacke
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Soluble Urokinase Receptor and Acute Kidney Injury
Salim S. Hayek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Landscape and Future Perspectives of Immunotherapy in Neuroendocrine Neoplasia
Ilaria Maggio et al.
CANCERS (2020)
Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer
Sven H. Loosen et al.
JHEP REPORTS (2020)
High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma
Sven H. Loosen et al.
CARCINOGENESIS (2019)
Management of Well-Differentiated High-Grade (G3) Neuroendocrine Tumors
Mohamad Bassam Sonbol et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2019)
Serum Levels of Kisspeptin Are Elevated in Patients with Pancreatic Cancer
Sven H. Loosen et al.
DISEASE MARKERS (2019)
Neuroendocrine neoplasia goes molecular - time for a change
Guido Rindi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Neutrophils are a main source of circulating suPAR predicting outcome in critical illness
Hendrik Gussen et al.
JOURNAL OF INTENSIVE CARE (2019)
Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67
C. G. Genc et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Practice guideline neuroendocrine tumors AWMF-Reg. 021-27
Anja Rinke et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2018)
Serum levels of soluble urokinase plasminogen activator receptor (suPAR) predict outcome after resection of colorectal liver metastases
Sven H. Loosen et al.
Oncotarget (2018)
Analysis of recurrence after the resection of pancreatic neuroendocrine tumors
Konstantinos Chouliaras et al.
JOURNAL OF SURGICAL ONCOLOGY (2018)
Competitive Testing of the WHO 2010 versus the WHO 2017 Grading of Pancreatic Neuroendocrine Neoplasms: Data from a Large International Cohort Study
Guido Rindi et al.
NEUROENDOCRINOLOGY (2018)
Novel biomarkers for sepsis: A narrative review
Frederik Fruergaard Larsen et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2017)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology-Diagnosis and Prognostic Stratification
Aurel Perren et al.
NEUROENDOCRINOLOGY (2017)
Neuropendocrine Cancer, Therapeutic Strategies in G3 Cancers
Anja Rinke et al.
DIGESTION (2017)
Prognostic Role of Circulating Soluble uPAR in Various Cancers: a Systematic Review and Meta-Analysis
K. L. Liu et al.
CLINICAL LABORATORY (2017)
Effects of liraglutide on cardiovascular risk biomarkers in patients with type 2 diabetes and albuminuria: A sub-analysis of a randomized, placebo-controlled, double-blind, crossover trial
Bernt Johan von Scholten et al.
DIABETES OBESITY & METABOLISM (2017)
Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology
Stefano Crippa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Serum soluble urokinase-type plasminogen activator receptor as a biological marker of bacterial infection in adults: a systematic review and meta-analysis
Wentao Ni et al.
SCIENTIFIC REPORTS (2016)
Circulating MicroRNAs as Biomarkers for Sepsis
Fabian Benz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
Eva Tiensuu Janson et al.
ACTA ONCOLOGICA (2014)
Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure
Alexander Koch et al.
LIVER INTERNATIONAL (2014)
Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study
H. Sorbye et al.
ANNALS OF ONCOLOGY (2013)
suPAR as a prognostic biomarker in sepsis
Katia Donadello et al.
BMC MEDICINE (2012)
Micro-RNA Profiling Reveals a Role for miR-29 in Human and Murine Liver Fibrosis
Christoph Roderburg et al.
HEPATOLOGY (2011)
Multiple activities of a multifaceted receptor: roles of cleaved and soluble uPAR
Nunzia Montuori et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases
Martin Illemann et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
The urokinase plasminogen activator receptor (uPAR) as a target for the diagnosis and therapy of cancer
AP Mazar
ANTI-CANCER DRUGS (2001)
分享论文
